Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 8,000 shares, a growth of 300.0% from the October 31st total of 2,000 shares. Based on an average trading volume of 18,100 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.1% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright dropped their price objective on shares of Cocrystal Pharma from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Thursday, August 22nd.

Cocrystal Pharma Trading Down 0.9 %

Shares of NASDAQ:COCP traded down $0.02 during midday trading on Thursday, hitting $2.10. The stock had a trading volume of 6,034 shares, compared to its average volume of 21,091. The company has a market capitalization of $21.36 million, a PE ratio of -1.14 and a beta of 1.45. The stock has a 50 day moving average price of $1.88 and a two-hundred day moving average price of $2.03. Cocrystal Pharma has a 1 year low of $1.33 and a 1 year high of $3.10.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.